Kiwi family move to Australia to get cystic fibrosis drug Trikafta for daughter

A Lower Hutt family relocated to Australia to access Trikafta, a groundbreaking cystic fibrosis medication for their 4-year-old daughter, to prevent irreversible damage to her health. While the drug is not yet funded in New Zealand, it significantly improves life expectancy by treating the condition’s cause rather than just its symptoms.

Want More Context? 🔎